Sandoz Gains An Edge With High-Concentration US Humira Biosimilar

Hyrimoz Version Of Adalimumab Approved By FDA In Citrate-Free 100mg/ml Form

High low 3D words
Sandoz now has FDA approval for both high and low strength adalimumab • Source: Shutterstock

More from Biosimilars

More from Products